Literature DB >> 10973816

Hinokitiol, a selective inhibitor of the platelet-type isozyme of arachidonate 12-lipoxygenase.

H Suzuki1, T Ueda, I Juránek, S Yamamoto, T Katoh, M Node, T Suzuki.   

Abstract

Hinokitiol (4-isopropyltropolone), a constituent of Japanese cypress, reversibly inhibited platelet-type 12-lipoxygenase with an IC(50) of 0.1 microM, and the enzyme activity was almost lost at 1 microM. The compound was much less active with other lipoxygenase enzymes with higher IC(50) values (leukocyte-type 12-lipoxygenase, 50 microM; soybean lipoxygenase, 17 microM; 15-lipoxygenase-1, >100 microM; 5-lipoxygenase, 17 microM). Hinokitiol up to 100 microM had almost no effect on cyclooxygenases-1 and -2. Their structure-activity relationship examined with various tropolone derivatives indicated the requirements of the 2-hydroxyl group and 4-alkyl group for the potent and selective inhibition of platelet-type 12-lipoxygenase. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973816     DOI: 10.1006/bbrc.2000.3390

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  12-lipoxygenase: a potential target for novel anti-platelet therapeutics.

Authors:  Jennifer Yeung; Michael Holinstat
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2011-07-01

2.  Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

Authors:  Victor Kenyon; Ganesha Rai; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Steven Perry; Netra Joshi; James M Bougie; William Leister; David A Taylor-Fishwick; Jerry L Nadler; Michael Holinstat; Anton Simeonov; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

Review 3.  Lipids and immunoinflammatory pathways of beta cell destruction.

Authors:  Yumi Imai; Anca D Dobrian; Margaret A Morris; David A Taylor-Fishwick; Jerry L Nadler
Journal:  Diabetologia       Date:  2016-02-11       Impact factor: 10.122

4.  Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries.

Authors:  Joshua D Deschamps; Jeffrey T Gautschi; Stephanie Whitman; Tyler A Johnson; Nadine C Gassner; Phillip Crews; Theodore R Holman
Journal:  Bioorg Med Chem       Date:  2007-08-22       Impact factor: 3.641

5.  Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.

Authors:  Lihong Zhang; Yang Peng; Ivan P Uray; Jianfeng Shen; Lulu Wang; Xiangdong Peng; Powel H Brown; Wei Tu; Guang Peng
Journal:  DNA Repair (Amst)       Date:  2017-10-24

Review 6.  Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications.

Authors:  A D Dobrian; M A Morris; D A Taylor-Fishwick; T R Holman; Y Imai; R G Mirmira; J L Nadler
Journal:  Pharmacol Ther       Date:  2018-10-19       Impact factor: 12.310

7.  Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.

Authors:  Yesseny Vasquez-Martinez; Rachana V Ohri; Victor Kenyon; Theodore R Holman; Silvia Sepúlveda-Boza
Journal:  Bioorg Med Chem       Date:  2007-08-22       Impact factor: 3.641

8.  Hinokitiol Negatively Regulates Immune Responses through Cell Cycle Arrest in Concanavalin A-Activated Lymphocytes.

Authors:  Chi-Li Chung; Kam-Wing Leung; Wan-Jung Lu; Ting-Lin Yen; Chia-Fu He; Joen-Rong Sheu; Kuan-Hung Lin; Li-Ming Lien
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-26       Impact factor: 2.629

Review 9.  One hundred years of benzotropone chemistry.

Authors:  Arif Dastan; Haydar Kilic; Nurullah Saracoglu
Journal:  Beilstein J Org Chem       Date:  2018-05-23       Impact factor: 2.883

10.  AMPK Activation Mediated by Hinokitiol Inhibits Adipogenic Differentiation of Mesenchymal Stem Cells through Autophagy Flux.

Authors:  Ju-Hee Lee; Jae-Kyo Jeong; Sang-Youel Park
Journal:  Int J Endocrinol       Date:  2018-07-10       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.